D-Glyceraldehyde-3-Phosphate Dehydrogenase: Three-Dimensional Structure and Evolutionary Significance (NAD Binding/Lactate Dehydrogenase/X-Ray Crystallography)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
(12) Patent Application Publication (10) Pub. No.: US 2004/0265809 A1 M0ras Et Al
US 2OO)4O265809A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0265809 A1 M0ras et al. (43) Pub. Date: Dec. 30, 2004 (54) POLYPEPTIDES DERIVED FROM RETINOIC Publication Classification ACID-RELATED ORPHAN RECEPTOR(ROIR) AND THEIR APPLICATIONS (51) Int. Cl.” ............................ C12Q 1/68; C07H 21/04; C07K 14/705 (76) Inventors: Dino Moras, Lampertheim (FR); (52) U.S. Cl. ......................... 435/6; 435/69.1; 435/320.1; Jean-Paul Renaud, Ostwald (FR); 435/325; 530/350; 536/23.5 Catherine Stehlin, Strasbourg (FR); Jean-Marie Strasbourg, Drusenheim (FR); Roland Schuele, Weisweil (DE); (57) ABSTRACT Eric Friedrich Greiner, Heidelberg (DE) The invention relates to polypeptides derived from the retinoic acid-related orphan receptor (ROR) in mammals, Correspondence Address: characterized in that they are delimited in their N-terminal ?RRET eXtremity by an amino-acid located between positions 1 to 2ND FLOOR 209, and in their C-terminal extremity by an amino-acid located between positions 450 to 452 of the rat RORß, o, or AIRLINGTON, VA 22202 (US) y, or by an amino-acid located at corresponding positions in nuclear receptor ROR of other Subtypes than C, ß and y, (21) Appl. No.: 10/477,116 and/or of the other mammals. The invention also relates to (22) PCT Filed: May 7, 2002 the use of these polypeptides, or of the molecular complexes 39 or the crystals containing them, for carrying out:—a process (86) PCT No.: PCT/EP02/05024 for the screening of a ROR-LBD ligand which is an agonist, or an antagonist of said receptor,—or a process for the (30) Foreign Application Priority Data analysis of the tridimensional structure of the complexes formed with said polypeptides, molecular complexes or May 7, 2001 (EP)....................................... -
K113436 B. Purpose for Submi
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k113436 B. Purpose for Submission: New device C. Measurand: Alkaline Phosphatase, Amylase, and Lactate Dehydrogenase D. Type of Test: Quantitative, enzymatic activity E. Applicant: Alfa Wassermann Diagnostic Technologies, LLC F. Proprietary and Established Names: ACE Alkaline Phosphatase Reagent Amylase Reagent ACE LDH-L Reagent G. Regulatory Information: Product Classification Regulation Section Panel Code CJE II 862.1050, Alkaline phosphatase 75-Chemistry or isoenzymes test system CIJ II 862.1070, Amylase test system 75-Chemistry CFJ II, exempt, meets 862.1440, Lactate 75-Chemistry limitations of dehydrogenase test system exemption. 21 CFR 862.9 (c) (4) and (9) H. Intended Use: 1. Intended use(s): See indications for use below. 2. Indication(s) for use: The ACE Alkaline Phosphatase Reagent is intended for the quantitative determination of alkaline phosphatase activity in serum using the ACE Axcel Clinical Chemistry System. Measurements of alkaline phosphatase are used in the diagnosis and treatment of liver, bone, parathyroid and intestinal diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE Amylase Reagent is intended for the quantitative determination α-amylase activity in serum using the ACE Axcel Clinical Chemistry System. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis (inflammation of the pancreas). This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE LDH-L Reagent is intended for the quantitative determination of lactate dehydrogenase activity in serum using the ACE Axcel Clinical Chemistry System. -
Diagnostic Value of Serum Enzymes-A Review on Laboratory Investigations
Review Article ISSN 2250-0480 VOL 5/ ISSUE 4/OCT 2015 DIAGNOSTIC VALUE OF SERUM ENZYMES-A REVIEW ON LABORATORY INVESTIGATIONS. 1VIDYA SAGAR, M.SC., 2DR. VANDANA BERRY, MD AND DR.ROHIT J. CHAUDHARY, MD 1Vice Principal, Institute of Allied Health Sciences, Christian Medical College, Ludhiana 2Professor & Ex-Head of Microbiology Christian Medical College, Ludhiana 3Assistant Professor Department of Biochemistry Christian Medical College, Ludhiana ABSTRACT Enzymes are produced intracellularly, and released into the plasma and body fluids, where their activities can be measured by their abilities to accelerate the particular chemical reactions they catalyze. But different serum enzymes are raised when different tissues are damaged. So serum enzyme determination can be used both to detect cellular damage and to suggest its location in situ. Some of the biochemical markers such as alanine aminotransferase, aspartate aminotransferase, alkaline phasphatase, gamma glutamyl transferase, nucleotidase, ceruloplasmin, alpha fetoprotein, amylase, lipase, creatine phosphokinase and lactate dehydrogenase are mentioned to evaluate diseases of liver, pancreas, skeletal muscle, bone, etc. Such enzyme test may assist the physician in diagnosis and treatment. KEYWORDS: Liver Function tests, Serum Amylase, Lipase, CPK and LDH. INTRODUCTION mitochondrial AST is seen in extensive tissue necrosis during myocardial infarction and also in chronic Liver diseases like liver tissue degeneration DIAGNOSTIC SERUM ENZYME and necrosis². But lesser amounts are found in Enzymes are very helpful in the diagnosis of brain, pancreas and lung. Although GPT is plentiful cardiac, hepatic, pancreatic, muscular, skeltal and in the liver and occurs only in the small amount in malignant disorders. Serum for all enzyme tests the other tissues. -
Inflammatory Mediators in Human Acute Pancreatitis
546 Gut 2000;47:546–552 Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological Gut: first published as 10.1136/gut.47.4.546 on 1 October 2000. Downloaded from implications J Mayer, B Rau, F Gansauge, H G Beger Abstract sources during the course of the disease.1 Background—The time course and rela- Studies on AP have demonstrated that these tionship between circulating and local mediators are produced in a variety of tissues in cytokine concentrations, pancreatic in- a predictable sequence, initiated by local flammation, and organ dysfunction in release of proinflammatory mediators such as acute pancreatitis are largely unknown. interleukin (IL)-1â, IL-6, and IL-8, which Patients and methods—In a prospective induce a systemic inflammatory response clinical study, we measured the pro- reflected by increased levels of soluble inter- inflammatory cytokines interleukin (IL)- leukin 2 receptor (sIL-2R), neopterin, or 1â, IL-6 and IL-8, the anti-inflammatory tumour necrosis factor á (TNF-á). This results cytokine IL-10, interleukin 1â receptor in inflammatory infiltration of distant organs antagonist (IL-1RA), and the soluble IL-2 with multiorgan failure and death.1 receptor (sIL-2R), and correlated our The systemic inflammatory response is kept findings with organ and systemic compli- at bay by local and systemic release of anti- cations in acute pancreatitis. In 51 pa- inflammatory mediators such as interleukin 1â tients with acute pancreatitis admitted receptor antagonist (IL-1RA) and IL-10 which within 72 hours after the onset of symp- were shown to reduce the severity of pancreatitis 2–5 toms, these parameters were measured and pancreatitis associated organ failure. -
IDH1R132H Mutation Inhibits the Proliferation and Glycolysis of Glioma Cells by Regulating the HIF- 1Α/LDHA Pathway
IDH1R132H Mutation Inhibits the Proliferation and Glycolysis of Glioma Cells by Regulating the HIF- 1α/LDHA Pathway Hailong Li PLAGH: Chinese PLA General Hospital Shuwei Wang Chinese PLA General Hospital Yonggang Wang ( [email protected] ) Beijing Tiantan Hospital https://orcid.org/0000-0002-8412-9244 Research Keywords: cell metabolism, glycolysis, isocitrate dehydrogenase, signal pathway, tumorgenesis Posted Date: March 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-299422/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: This study aims to explore the role and underlying mechanism of the IDH1R132H in the growth, migration, and glycolysis of glioma cells. Methods: The alternation of IDH1, HIF-1α, and LDHA genes in 283 LGG sample (TCGA LGG database) was analyzed on cBioportal. The expression of these three genes in glioma tissues with IDH1R132H mutation or IDH1 wild type (IDH1-WT) and normal brain tissues was also assessed using immunohistochemistry assay. In addition, U521 glioma cells were transfected with IDH1-WT or IDH1R132H to explore the role of IDH1 in the proliferation and migration of glioma cells in vitro. Cell growth curve, Transwell mitigation assay, and assessment of glucose consumption and lactate production were conducted to evaluate the proliferation, migration, and glycolysis of glioma cells. Results: The expression of HIF-1α and LDHA in IDH1R132H mutant was signicantly lower than that in glioma cells with wild type IDH1 (P<0.05). IDH1R132H inhibited the proliferation and glycolysis of U521 glioma cells. Conclusion: The IDH1 mutation IDH1R132H plays an important role in the occurrence and development of glioma through inhibiting the expression of HIF-1α and glycolysis. -
21 CFR Ch. I (4–1–10 Edition) § 862.1440
§ 862.1440 21 CFR Ch. I (4–1–10 Edition) intended to identify ketones in urine Lactic acid measurements that evalu- and other body fluids. Identification of ate the acid-base status are used in the ketones is used in the diagnosis and diagnosis and treatment of lactic aci- treatment of acidosis (a condition dosis (abnormally high acidity of the characterized by abnormally high acid- blood). ity of body fluids) or ketosis (a condi- (b) Classification. Class I (general con- tion characterized by increased produc- trols). The device is exempt from the tion of ketone bodies such as acetone) premarket notification procedures in and for monitoring patients on subpart E of part 807 of this chapter ketogenic diets and patients with dia- subject to § 862.9. betes. (b) Classification. Class I (general con- [52 FR 16122, May 1, 1987, as amended at 65 trols). The device is exempt from the FR 2307, Jan. 14, 2000] premarket notification procedures in § 862.1455 Lecithin/sphingomyelin subpart E of part 807 of this chapter ratio in amniotic fluid test system. subject to § 862.9. (a) Identification. A lecithin/ [52 FR 16122, May 1, 1987, as amended at 65 sphingomyelin ratio in amniotic fluid FR 2307, Jan. 14, 2000] test system is a device intended to § 862.1440 Lactate dehydrogenase test measure the lecithin/sphingomyelin system. ratio in amniotic fluid. Lecithin and sphingomyelin are phospholipids (fats (a) Identification. A lactate dehydro- or fat-like substances containing phos- genase test system is a device intended phorus). Measurements of the lecithin/ to measure the activity of the enzyme sphingomyelin ratio in amniotic fluid lactate dehydrogenase in serum. -
Structural Biology in Strasbourg, a Tribute to Dino Moras June, 12Th 2019 Auditorium IGBMC
Structural Biology in Strasbourg, a tribute to Dino Moras June, 12th 2019 Auditorium IGBMC Speakers : Pierre Chambon David Stuart IGBMC, Strasbourg Illkirch, France Oxford University, Oxford, UK Jean-Marc Egly Akio Takenaka IGBMC, Strasbourg Illkirch, France Chiba Institute of Technology, Narashino, Japan Jack Johnson Eric Westhof The Scripps Research Institute, La Jolla IBMC, Strasbourg, France Bruno Klaholz Shigeyuki Yokoyama IGBMC, Strasbourg Illkirch, France RIKEN, Yokohama City, Japan Jean-Marie Lehn Marat Yusupov ISIS, Strasbourg, France IGBMC, Strasbourg Illkirch, France Anders Liljas Giuseppe Zaccai CMPS, Lund University, Sweden IBS, Grenoble, France Jean-Louis Mandel IGBMC, Strasbourg Illkirch, France IGBMC - 1 rue Laurent Fries 67404 Illkirch Cedex - www.igbmc.fr The Institute of Genetics and Molecular and Cellular Biology (IGBMC) organizes the symposium entitled “Structural Biology in Strasbourg, a tribute to Dino Moras” on Wednesday, June 12, 2019 to pay tribute to the scientific endeavor of Professor Dino MORAS, a leading researcher, recognized at the international level for its expertise in Structural Biology. Member of the French Academy of Sciences and former director of the IGBMC, Dino Moras introduced biological crystallography in Strasbourg and promoted the development of Structural Biology in France. With his team, he devoted himself to understanding at the atomic level, the transmission of genetic information from DNA into proteins. He studied the aminoacylation reaction of the transfer RNAs, one of the key steps in the translation of genetic information and highlighted in particular, the partitioning of aminoacyl-tRNA synthetases into two classes and determined the first atomic structure of a complex between a transfer RNA and a class II enzyme. -
Observation and Identification of Lactate Dehydrogenase Anomaly in a Postburn Patient Postgrad Med J: First Published As on 5 August 2004
481 ORIGINAL ARTICLE Observation and identification of lactate dehydrogenase anomaly in a postburn patient Postgrad Med J: first published as on 5 August 2004. Downloaded from Z-J Liu, Y Zhang, X-B Zhang, X Yang ............................................................................................................................... Postgrad Med J 2004;80:481–483. doi: 10.1136/pgmj.2003.015420 See end of article for authors’ affiliations Objective: Lactate dehydrogenase (LDH) anomaly is one of the macroenzymes. Macroenzymes are ....................... enzymes in serum that have formed high molecular mass complexes, either by self polymerisation or by Correspondence to: association with other serum components. The aim of this study was to identify the properties of LDH Professor Ze-Jun Liu, anomaly and observe the changes from admission to discharge in a postburn patient with LDH anomaly in Department of Laboratory Medicine, Southwest his serum. Hospital, Third Military Methods: LDH isoenzymes of the serum were electrophoretically fractionated with terylene cellulose Medical University, acetate supporting media; LDH anomaly was identified by counter immunoelectrophoresis. Chongqing 400038 Peoples’ Republic of Results: An abnormal LDH-4 band and an extra band on the cathode of LDH-5 were observed in the China; a65424208@ serum of this patient and were found to be part of an LDH-IgG complex. As his symptoms improved, the online.cq.cn patient’s LDH anomaly gradually disappeared. The appearance and disappearance of the anomaly seemed to be related to the progression of the patient’s burns. Submitted 26 September 2003 Conclusion: In clinical practice, it is important to keep in mind the possibility of an LDH anomaly in patients Accepted 30 October 2003 when the LDH level is abnormally high or does not seem to be related to the clinical state. -
Structure of Bacteriophage T4 Fibritin M: a Troublesome Packing Arrangement
805 Acta Cryst. (1998). D54, 805-816 Structure of Bacteriophage T4 Fibritin M: a Troublesome Packing Arrangement SERGEI W. STRELKOV,a'b YIZHI TAO, a MIKHAIL M. St-INEIDER,b VADIM W. MESYANZHINOV b AND MICHAEL G ROSSMANN a* "Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-1392, USA, and hShemyakin- Ovchnikov Institute of Bioorganic Chemistry, 16/10 Miklukho-Maklaya Street, Moscow 117 871, Russia. E-mail: mgr@indiana, bio.purdue, edu (Received 19 September 1997; accepted 8 December 1997) Abstract flanked by small globular domains at both ends. As in other coiled-coil structures, the amino-acid sequence of Fibritin, a 52 kDa product of bacteriophage T4 gene fibritin (486 residues) has a distinct heptad repeat wac, forms 530 A long fibers, named whiskers, that (abcdefg)n which contains predominantly hydrophobic attach to the phage neck and perform a helper function residues at the a and d positions, while the other posi- during phage assembly. Fibritin is a homotrimer, with its tions are occupied mostly by polar residues. Since seven predominant central domain consisting of 12 consecu- residues make approximately two a-helical turns, the tive c~-helical coiled-coil segments linked together by hydrophobic residues of consecutive heptads are located loops. The central domain is flanked by small globular on one side of the helix, and this provides for the domains at both ends. Fibritin M is a genetically formation of the coiled-coil core (Lupas, 1996). An engineered fragment of the wild type and contains 74 unusual feature of fibritin is that the coiled coil is amino-acid residues corresponding to the last coiled-coil interrupted by insertion of loops, consisting of five to 20 segment and the complete carboxy-terminal domain. -
Effect of Selenium Supplementation on Serum Amylase, Lactate Dehydrogenase and Alkaline Phosphatase Activities in Rats Exposed to Cadmium Or Lead
EFFECT OF SELENIUM SUPPLEMENTATION ON RATS EXPOSED TO CADMIUM OR LEAD Cercetări Agronomice în Moldova Vol. XLVII , No. 4 (160) / 2014 EFFECT OF SELENIUM SUPPLEMENTATION ON SERUM AMYLASE, LACTATE DEHYDROGENASE AND ALKALINE PHOSPHATASE ACTIVITIES IN RATS EXPOSED TO CADMIUM OR LEAD B.G. ŞLENCU1*, C. CIOBANU1, Carmen SOLCAN 2, Alina ANTON2, St. CIOBANU2, Gh. SOLCAN2, Rodica CUCIUREANU1 *E-mail: [email protected] Received June 13, 2014 ABSTRACT. The purpose of the study was Selenium, coadministered with cadmium, to assess the effect of selenium caused a marked increase in serum LDH supplementation on serum amylase, lactate activity, when compared to cadmium alone dehydrogenase (LDH) and alkaline or Control group while practically it had no phosphatase (ALP) activities in rats, during effect on lead induced changes in LDH subacute exposure to toxic doses of activity. Cadmium and lead induced cadmium or lead through the drinking disturbances in serum ALP activity were not water. The experimental groups (n=6) were: influenced by selenium supplementation. Control, Se (Se+4: 0,2 mg/l), Cd (Cd+2: 150 mg/l), Pb (Pb+2: 300 mg/l), Cd+Se (Cd+2: Key words: Rats; Lead; Cadmium; 150 mg/l; Se+4: 0,2 mg/l) and Pb+Se (Pb+2: Selenium; Blood serum enzyme. 300 mg/l; Se+4: 0,2 mg/l). The animals were sacrificed after 56 days. Amylase, LDH and REZUMAT. Efectul suplimentării cu ALP activities were determined from serum. seleniu asupra activităţii amilazei serice, Se and Pb treatments caused an increase in a lactat dehidrogenazei şi a fosfatazei amylase and LDH activities, when alcaline la sobolani, expuşi la cadmiu sau compared to Control group while Cd caused plumb. -
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism Jose L
Published OnlineFirst June 4, 2015; DOI: 10.1158/0008-5472.CAN-15-0840 Cancer Integrated Systems and Technologies Research IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism Jose L. Izquierdo-Garcia1, Pavithra Viswanath1, Pia Eriksson1, Larry Cai1, Marina Radoul1, Myriam M. Chaumeil1, Michael Blough2, H. Artee Luchman3, Samuel Weiss2, J. Gregory Cairncross2, Joanna J. Phillips4, Russell O. Pieper4, and Sabrina M. Ronen1 Abstract Mutant isocitrate dehydrogenase 1 (IDH1) catalyzes the pro- a reduction in metabolism of hyperpolarized 2-13C-pyruvate to duction of 2-hydroxyglutarate but also elicits additional meta- 5-13C-glutamate, relative to cells expressing wild-type IDH1. 13C- bolic changes. Levels of both glutamate and pyruvate dehydro- MRS also revealed a reduction in glucose flux to glutamate in genase (PDH) activity have been shown to be affected in U87 IDH1 mutant cells. Notably, pharmacological activation of PDH glioblastoma cells or normal human astrocyte (NHA) cells expres- by cell exposure to dichloroacetate (DCA) increased production sing mutant IDH1, as compared with cells expressing wild-type of hyperpolarized 5-13C-glutamate in IDH1 mutant cells. Fur- IDH1. In this study, we show how these phenomena are linked thermore, DCA treatment also abrogated the clonogenic advan- through the effects of IDH1 mutation, which also reprograms tage conferred by IDH1 mutation. Using patient-derived mutant pyruvate metabolism. Reduced PDH activity in U87 glioblastoma IDH1 neurosphere models, we showed that PDH activity was and NHA IDH1 mutant cells was associated with relative increases essential for cell proliferation. Taken together, our results estab- in PDH inhibitory phosphorylation, expression of pyruvate dehy- lished that the IDH1 mutation induces an MRS-detectable repro- drogenase kinase-3, and levels of hypoxia inducible factor-1a. -
Alanine Transaminase Assay (ALT) Catalog #8478 100 Tests in 96-Well Plate
Alanine Transaminase Assay (ALT) Catalog #8478 100 Tests in 96-well plate Product Description Alanine Aminotransferase (ALT), also known as serum glutamic-pyruvic transaminase (SGPT), catalyzes the reversible transfer of an amino group from alanine to α-ketoglutarate. The products of this transamination reaction are pyruvate and glutamate. ALT is found primarily in liver and serum, but occurs in other tissues as well. Significantly elevated serum ALT levels often suggest the existence of medical problems, such as hepatocellular injury, hepatitis, diabetes, bile duct problem and myopathy. This colorimetric assay is based on the oxidization of NADH to NAD in the presence of pyruvate and lactate dehydrogenase. The ALT activity is determined by assaying the rate of NADH oxidation, which is proportional to the reduction in absorbance at 340nm over time (ΔOD340nm/min). Kit Components Cat. No. # of vials Reagent Quantity Storage 8478a 1 Assay buffer 10 mL -20°C 8478b 1 ALT standard 10 µL -20°C 8478c 1 Substrate mix 1.0 mL -20°C 8478d 1 Cofactor 0.8 mL -20°C 8478e 1 Enzyme 0.2 mL -80°C Product Use The ALT kit measures the alanine transaminase activity of different types of samples, such as serum, plasma and tissues. ALT is for research use only. It is not approved for human or animal use, or for application in in vitro diagnostic procedures. Quality Control Serially diluted alanine transaminase solutions with concentrations ranging from 0.03125 to 1.0 U/mL are measured with the ScienCell™ Alanine Transaminase Assay kit. The decrease in OD340nm is monitored as a function of time (Figure 1) and the resulting standard of ∆OD340nm/min vs alanine transaminase activity are plotted (Figure 2).